Centre Hospitalier Mère Et Enfant Monkole

UEI
KB5LZ62AK819
CAGE
SCXH2
Primary NAICS
622310 Specialty (except Psychiatric and Substance Abuse) Hospitals
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
International Organization
SAM.gov registration date
Website
monkole.cd
Founded
1991
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant subawards

Prime recipient Prime award Amount Awarded
Childrens Hospital Medical Center Realizing Effectiveness Across Continents with Hydroxyurea (REACH): A Phase I/ll Pilot Study of Hydroxyurea for Children with Sickle Cell Anemia U01HL133883 $178,823
Childrens Hospital Medical Center Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea (REACH U01HL133883 $68,837

Similar vendors

About the company

Centre Hospitalier Mère Et Enfant Monkole is an international non-profit organization located in the Democratic Republic of the Congo. According to its website, it is a general hospital that prioritizes providing excellent care to vulnerable communities, particularly mothers and children, through its two main branches. It was registered to receive awards from the U.S. federal government from May 2017 to June 2022.

Centre Hospitalier Mère Et Enfant Monkole has provided services through multiple sub-awards under the "Realizing Effectiveness Across Continents with Hydroxyurea (REACH)" grant program administered by the prime grantee Children's Hospital Medical Center. The sub-awards describe a Phase I/II pilot study investigating the use of hydroxyurea, a medication, for treatment of children with sickle cell anemia. This appears to be a clinical research study evaluating the effectiveness and safety of this drug therapy for pediatric sickle cell patients in the Democratic Republic of the Congo. The sub-awards suggest Centre Hospitalier Mère Et Enfant Monkole likely served as a clinical site and provided medical care and data collection for this multinational research initiative funded by a U.S. federal grant.

Quick answers

Is Centre Hospitalier Mère Et Enfant Monkole registered in SAM.gov?

Centre Hospitalier Mère Et Enfant Monkole's SAM.gov registration expired on June 11, 2022.

On GovTribe

See Centre Hospitalier Mère Et Enfant Monkole's full federal record

  • Similar vendors